Bridging the Gap: Collaborative Efforts on Liver Health, Obesity & Diabetes

European Coalition for People with Obesity (ECPO) and the European Liver Patients’ Association (ELPA) are excited to launch a collaborative training session, generously supported by Boehringer Ingelheim, Novo Nordisk, Gilead, Lilly, EASO and Boston Scientific.

While our supporters contribute to funding, they hold no influence over the selection, content, or execution of our activities. All materials and sessions are developed independently by ECPO and ELPA as patient-led organisations, ensuring the integrity and focus of our training remain patient-centered.

Logo collage of ECPO, Boehringer Ingelheim, Lilly, Novo Nordisk, EASO, and Boston Scientific, indicating support for an initiative related to obesity.
Logos of the European Liver Patients' Association, Boehringer Ingelheim, Novo Nordisk, and Gilead. "Supported by" text above Novo Nordisk logo.